Active ingredient

Registrations named Hydroxychloroquine

Hydroxychloroquine is an active ingredient, not a brand name. 8 registrations in the DRAP register carry it in the product name, and the price index attributes them to 2 manufacturers — these are generic products, not one company's range.

Registrations
8
Manufacturers
2
Dosage forms
Tablet
Approved price range
Rs 408.12 – Rs 830.97

Registrations

Registered nameReg. No.StrengthFormManufacturerPrice from
Hydroxychloroquine 200mg008870-EX200mg———
Hydroxychloroquine 200mg Tablet101883200mgTablet——
Hydroxychloroquine 200mg Tablet102284200mgTablet——
Hydroxychloroquine 200mg Tablet106010200mgTabletMedifine Laboratories (Pvt) Ltd.Rs 498.59
Hydroxychloroquine Tablet102662—Tablet——
Hydroxychloroquine Tablet103682—Tablet——
Hydroxychloroquine Tablet 200mg101281200mgTabletScilife Pharma Private LimitedRs 408.12
Hydroxychloroquine Tablet 200mg101324200mgTablet——

Why this is not described as a brand

The DRAP register has no separate brand column, so an ingredient name and a trade name look identical in the data. This group is an ingredient: the products below are made by different companies under their own trade names, and no single company owns the word.

How these are grouped

These registrations are grouped by the words in their registered name. Strength, pack size, dosage form and trailing variant words such as Forte, Extra, CF, DS and XR are removed before grouping, so Panadol Tablet, Panadol CF Tablet and Panadol Extra Tablet count as one group. Names that only share a first word but mean different things — for example two companies' unrelated products — can still land together; the registered name of every row is shown so the grouping is checkable.

Source: the bundled DRAP registered-products index and the DRAP price index. Prices are regulatory listings, not pharmacy stock or a retail quote.